Theres very few, if not only one, human trial that was a retrospective study, looking at knee pain, and they injected people with BPC-157
Assessing positive and negative valence systems to refine animal models of bipolar disorders: the example of GBR 12909-induced manic phenotype
Nevertheless, researchers may consider cycling the subject off the peptide for four weeks after every four to eight weeks of therapy
Preclinical research Pharmacodynamic research: Evaluating the efficacy of creams in animal models, such as promoting wound healing and anti-inflammatory effects
Lancet (2021) 398:14355
During 72 weeks of treatment, people taking tirzepatide at doses of 5, 10, or 15 mg lost an average of 15.0%, 19.5%, and 20.9%, respectively, compared with just 3.1% in people taking a placebo